Montelukast

Montelukast (trade name Singulair)(Openair in Pakistan) is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. It is usually administered orally. Montelukast is a CysLT1 antagonist; that is it blocks the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1 in the lungs and bronchial tubes by binding to it. This reduces the bronchoconstriction otherwi... more

Also known as:

  • Singulair

Medicine

ATC Code:

  • R03DC03

Drugbank:

  • APRD00434

Pubchem:

  • 60,951

CAS Number:

  • 158966-92-8

Legal status:

top ↑ top ↑

Facts from the Community

From the BioVenturist base

Technology involved:

Sales:

Amount Year Area
  • 2,975,600,000
  • 2005
  • 4,266,300,000
  • 2007
  • 3,579,000,000
  • 2006
View entire collection »

Developed by:

Brand Names:

  • Singulair

Stage of development:

Indication or disease:

Disease Phase of development
View entire collection »

Patent Expiration:

  • 2012
top ↑

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Montelukast was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution